Results 141 to 150 of about 2,997 (217)

PET-CT Imaging in Breast Cancer Patients: New Tracers, Future Directions [PDF]

, 2013
Dank, Magdolna, Györke, Tamás, Kajáry K,, Lengyel Zs,, Torgyik, László, Tőkés, Tímea   +5 more
core   +1 more source

Noninvasive Evaluation of Trop2 Expression Using ⁶⁴Cu-NOTA-Trodelvy-F(ab')₂ in Gastric and Pancreatic Cancer. [PDF]

Mol Pharm
Huang W, Chao F, Li R, Yang Y, Hsu JC, DeLuca MC, Engle JW, Han X, Kang L, Cai W.   +9 more
europepmc   +1 more source

Letter to editor: detection of immune-mediated tumour cell death in vivo using Zirconium-89-labeled APOMAB®. [PDF]

J Transl Med
Liu D, Liu L, Che X, Wu G, Wu G.
europepmc   +1 more source

Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors [PDF]

, 2018
Achilefu, Samuel, et al,
core   +1 more source

The impact of weakly bound ⁸⁹Zr on preclinical studies: Non-specific accumulation in solid tumors and aspergillus infection [PDF]

, 2015
Hansen, Anders Elias, Hasenberg, Mike, Jensen, Andreas Tue Ingemann, Jørgensen, Jesper T., Kjær, Andreas, Maurer, Andreas, Pichler, Bernd, Rolle, Anna-Maria, Severin, Gregory, Wiehr, Stefan   +9 more
core   +1 more source

A zirconium-89-labeled antibody-drug conjugate PET probe for noninvasive monitoring of Nectin4 expression in breast cancer and lung cancer. [PDF]

Cell Rep Phys Sci
Huang W, Wang T, Liang Y, Chao F, Yang Q, Barnhart TE, Engle JW, Li L, Kang L, Cai W.   +9 more
europepmc   +1 more source

TROP2-targeted molecular imaging: a promising tool for precision oncology. [PDF]

Am J Nucl Med Mol Imaging
Ye L, Chen H, Wu D.
europepmc   +1 more source

Development of Zr-89-Ontuxizumab for in vivo TEM-1/endosialin PET applications [PDF]

, 2016
Lange, Sara E. S., Lapi, Suzanne E., O\u27Shannessy, Daniel J., Studer, Matthew, Van Tine, Brian A., Zheleznyak, Alex   +5 more
core   +1 more source

Highlights lecture EANM 2014: “Gimme gimme gimme those nuclear Super Troupers” [PDF]

, 2015

core   +1 more source

Targeting Claudin18.2 for cancer theranostics: From molecular imaging to precision therapy. [PDF]

iScience
Liu Y, Huang W, Hsu JC, Sun Z, Cai W, Kang L.   +5 more
europepmc   +1 more source